Genetic Testing for All Breast Cancer Patients (GET FACTS)

Breast Cancer Clinical Trial

Official title: Genetic Testing for All Breast Cancer Patients (GET FACTS)

Status Active, not recruiting

Clinical Trial Summary

This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer

This research study involves an expedited and surgery-specific form of genetic counseling.

The names of the study methods involved in this trial are/is:

• Quantitative genetic counseling (discussion is guided by tables and graphs)

• Standard genetic counseling

Clinical Trial Description

• The research study procedures include screening for eligibility and study interventions including evaluations and follow up visits

• After receiving genetic testing, participants will be placed into one of two counseling methodology groups:

• Standard genetic counseling: Standard of care discussion

• Quantitative genetic counseling: Discussion is guided by tables and graphs.

• Participants will be on the research study for up to six months, with an optional extension to two years.

• It is expected that about 450 people will participate.

• This research study is a Feasibility Study, which is the first-time investigators are examining this form of genetic counseling.

• This is a randomized study. Randomization means being put into a group by chance. It is like flipping a coin. Neither the participant nor the Investigator will choose the group the participant is assigned to. ;

Related Conditions & MeSH terms

• Breast Cancer
• Breast Carcinoma In Situ
• Breast Neoplasms
• Genetic Testing
• in Situ Breast Cancer
• Invasive Breast Cancer

• NCT number: NCT04245176
• Study type: Interventional
• Source: Dana-Farber Cancer Institute
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 31, 2020
• Completion date: December 1, 2024